• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Forbion European Acquisition Corp.

    10/10/23 11:15:28 AM ET
    $FRBN
    Blank Checks
    Finance
    Get the next $FRBN alert in real time by email
    SC 13G 1 d449835dsc13g.htm SC 13G SC 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. ___)*

     

     

    Forbion European Acquisition Corp.

    (Name of Issuer)

    Class A Ordinary Shares, par value $0.0001 per share

    (Title of Class of Securities)

    G3619H102

    (CUSIP Number)

    October 3, 2023

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. G3619H102

     

     (1)   

     Names of reporting persons

     

     Sculptor Capital LP

     (2)  

     Check the appropriate box if a member of a group (see instructions)

     

     ☐ (a)  ☒ (b)

     (3)  

     SEC use only

     

     (4)  

     Citizenship or place of organization

     

     Delaware

    Number of

    shares  beneficially 

    owned by

    each

    reporting

    person

    with:

       (5)   

     Sole voting power

     

     0

       (6)  

     Shared voting power

     

     1,242,391

       (7)  

     Sole dispositive power

     

     0

       (8)  

     Shared dispositive power

     

     1,242,391

     (9)   

     Aggregate amount beneficially owned by each reporting person

     

     1,242,391

    (10)  

     Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    (11)  

     Percent of class represented by amount in Row (9)

     

     9.82%

    (12)  

     Type of reporting person (see instructions)

     

     IA


    CUSIP No. G3619H102

     

     (1)   

     Names of reporting persons

     

     Sculptor Capital II LP

     (2)  

     Check the appropriate box if a member of a group (see instructions)

     

     ☐ (a)  ☒ (b)

     (3)  

     SEC use only

     

     (4)  

     Citizenship or place of organization

     

     Delaware

    Number of

    shares  beneficially 

    owned by

    each

    reporting

    person

    with:

       (5)   

     Sole voting power

     

     0

       (6)  

     Shared voting power

     

     1,242,391

       (7)  

     Sole dispositive power

     

     0

       (8)  

     Shared dispositive power

     

     1,242,391

     (9)   

     Aggregate amount beneficially owned by each reporting person

     

     1,242,391

    (10)  

     Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    (11)  

     Percent of class represented by amount in Row (9)

     

     9.82%

    (12)  

     Type of reporting person (see instructions)

     

     IA


    CUSIP No. G3619H102

     

     (1)   

     Names of reporting persons

     

     Sculptor Capital Holding Corp.

     (2)  

     Check the appropriate box if a member of a group (see instructions)

     

     ☐ (a)  ☒ (b)

     (3)  

     SEC use only

     

     (4)  

     Citizenship or place of organization

     

     Delaware

    Number of

    shares  beneficially 

    owned by

    each

    reporting

    person

    with:

       (5)   

     Sole voting power

     

     0

       (6)  

     Shared voting power

     

     1,242,391

       (7)  

     Sole dispositive power

     

     0

       (8)  

     Shared dispositive power

     

     1,242,391

     (9)   

     Aggregate amount beneficially owned by each reporting person

     

     1,242,391

    (10)  

     Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    (11)  

     Percent of class represented by amount in Row (9)

     

     9.82%

    (12)  

     Type of reporting person (see instructions)

     

     CO


    CUSIP No. G3619H102

     

     (1)   

     Names of reporting persons

     

     Sculptor Capital Holding II LLC

     (2)  

     Check the appropriate box if a member of a group (see instructions)

     

     ☐ (a)  ☒ (b) 

     (3)  

     SEC use only

     

     (4)  

     Citizenship or place of organization

     

     Delaware

    Number of

    shares  beneficially 

    owned by

    each

    reporting

    person

    with:

       (5)   

     Sole voting power

     

     0

       (6)  

     Shared voting power

     

     1,242,391

       (7)  

     Sole dispositive power

     

     0

       (8)  

     Shared dispositive power

     

     1,242,391

     (9)   

     Aggregate amount beneficially owned by each reporting person

     

     1,242,391

    (10)  

     Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    (11)  

     Percent of class represented by amount in Row (9)

     

     9.82%

    (12)  

     Type of reporting person (see instructions)

     

     CO

     


    CUSIP No. G3619H102

     

     (1)   

     Names of reporting persons

     

     Sculptor Capital Management, Inc.

     (2)  

     Check the appropriate box if a member of a group (see instructions)

     

     ☐ (a)  ☒ (b) 

     (3)  

     SEC use only

     

     (4)  

     Citizenship or place of organization

     

     Delaware

    Number of

    shares  beneficially 

    owned by

    each

    reporting

    person

    with:

       (5)   

     Sole voting power

     

     0

       (6)  

     Shared voting power

     

     1,242,391

       (7)  

     Sole dispositive power

     

     0

       (8)  

     Shared dispositive power

     

     1,242,391

     (9)   

     Aggregate amount beneficially owned by each reporting person

     

     1,242,391

    (10)  

     Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    (11)  

     Percent of class represented by amount in Row (9)

     

     9.82%

    (12)  

     Type of reporting person (see instructions)

     

     CO

     


    CUSIP No. G3619H102

     

     (1)   

     Names of reporting persons

     

     Sculptor Master Fund, Ltd.

     (2)  

     Check the appropriate box if a member of a group (see instructions)

     

     ☐ (a)  ☒ (b) 

     (3)  

     SEC use only

     

     (4)  

     Citizenship or place of organization

     

     Cayman Islands

    Number of

    shares  beneficially 

    owned by

    each

    reporting

    person

    with:

       (5)   

     Sole voting power

     

       (6)  

     Shared voting power

     

     1,173,750

       (7)  

     Sole dispositive power

     

       (8)  

     Shared dispositive power

     

     1,173,750

     (9)   

     Aggregate amount beneficially owned by each reporting person

     

     1,173,750

    (10)  

     Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    (11)  

     Percent of class represented by amount in Row (9)

     

     9.28%

    (12)  

     Type of reporting person (see instructions)

     

     CO

     


    CUSIP No. G3619H102

     

     (1)   

     Names of reporting persons

     

     Sculptor Special Funding, LP

     (2)  

     Check the appropriate box if a member of a group (see instructions)

     

     ☐ (a)  ☒ (b) 

     (3)  

     SEC use only

     

     (4)  

     Citizenship or place of organization

     

     Cayman Islands

    Number of

    shares  beneficially 

    owned by

    each

    reporting

    person

    with:

       (5)   

     Sole voting power

     

       (6)  

     Shared voting power

     

     1,173,750

       (7)  

     Sole dispositive power

     

       (8)  

     Shared dispositive power

     

     1,173,750

     (9)   

     Aggregate amount beneficially owned by each reporting person

     

     1,173,750

    (10)  

     Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    (11)  

     Percent of class represented by amount in Row (9)

     

     9.28%

    (12)  

     Type of reporting person (see instructions)

     

     CO

     

     


    CUSIP No. G3619H102

     

     (1)   

     Names of reporting persons

     

     Sculptor Credit Opportunities Master Fund, Ltd.

     (2)  

     Check the appropriate box if a member of a group (see instructions)

     

     ☐ (a)  ☒ (b)

     (3)  

     SEC use only

     

     (4)  

     Citizenship or place of organization

     

     Cayman Islands

    Number of

    shares  beneficially 

    owned by

    each

    reporting

    person

    with:

       (5)   

     Sole voting power

     

       (6)  

     Shared voting power

     

     19,234

       (7)  

     Sole dispositive power

     

       (8)  

     Shared dispositive power

     

     19,234

     (9)   

     Aggregate amount beneficially owned by each reporting person

     

     19,234

    (10)  

     Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    (11)  

     Percent of class represented by amount in Row (9)

     

     0.15%

    (12)  

     Type of reporting person (see instructions)

     

     CO


    CUSIP No. G3619H102

     

     (1)   

     Names of reporting persons

     

     Sculptor SC II LP

     (2)  

     Check the appropriate box if a member of a group (see instructions)

     

     ☐ (a)  ☒ (b)

     (3)  

     SEC use only

     

     (4)  

     Citizenship or place of organization

     

     Delaware

    Number of

    shares  beneficially 

    owned by

    each

    reporting

    person

    with:

       (5)   

     Sole voting power

     

       (6)  

     Shared voting power

     

     49,407

       (7)  

     Sole dispositive power

     

       (8)  

     Shared dispositive power

     

     49,407

     (9)   

     Aggregate amount beneficially owned by each reporting person

     

     49,407

    (10)  

     Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    (11)  

     Percent of class represented by amount in Row (9)

     

     0.39%

    (12)  

     Type of reporting person (see instructions)

     

     CO


      •  

    Sculptor Capital LP (“Sculptor”), a Delaware limited partnership, is the principal investment manager to a number of private funds and discretionary accounts (collectively, the “Accounts”).

     

      •  

    Sculptor Capital II LP (“Sculptor-II”), a Delaware limited partnership that is wholly owned by Sculptor, also serves as the investment manager to certain of the Accounts. The Ordinary Shares reported in this Schedule 13G are held in the Accounts managed by Sculptor and Sculptor-II.

     

      •  

    Sculptor Capital Holding Corporation (“SCHC”), a Delaware corporation, serves as the general partner of Sculptor.

     

      •  

    Sculptor Capital Holding II LLC (“SCHC-II”), a Delaware limited liability company that is wholly owned by Sculptor, serves as the general partner of Sculptor-II.

     

      •  

    Sculptor Capital Management, Inc. (“SCU”), a Delaware limited liability company, is a holding company that is the sole shareholder of SCHC and the ultimate parent company of Sculptor and Sculptor-II.

     

      •  

    Sculptor Master Fund, Ltd. (“SCMF”) is a Cayman Islands company. Sculptor is the investment adviser to SCMF.

     

      •  

    Sculptor Special Funding, LP (“NRMD”) is a Cayman Islands exempted limited partnership that is wholly owned by SCMF.

     

      •  

    Sculptor Credit Opportunities Master Fund, Ltd. (“SCCO”) is a Cayman Islands company. Sculptor is the investment adviser to SCCO.

     

      •  

    Sculptor SC II LP (“NJGC”) is a Delaware limited partnership. Sculptor-II is the investment adviser to NJGC.

     

      •  

    The address of the principal business office of Sculptor, Sculptor-II, SCHC, SCHC-II, and SCU is 9 West 57 Street, 39 Floor, New York, NY 10019.

     

      •  

    The address of the principal business office of SCMF and SCCO is c/o State Street (Cayman) Trust, Limited, 1 Nexus Way - Suite #5203, PO Box 896, Helicona Courtyard, Camana Bay, Grand Cayman, KY1-1103, Cayman.

     

      •  

    The address of the principal business office of NRMD is c/o MaplesFS Limited, P.O. Box 1093, Queensgate House, Grand Cayman, KY1-1102, Cayman Islands.

     

      •  

    The address of the principal business office of NJGC is c/o The Corporation Trust Company 1209 Orange Street, Wilmington DE 19801.


    Item 1(a)

    Name of issuer:

    Forbion European Acquisition Corp., a Cayman Island exempt company (the “Issuer”)

     

    Item 1(b)

    Address of issuer’s principal executive offices:

    4001 Kennett Pike, Suite 302

    Wilmington, DE 19807

    2(a) Name of person filing:

    Sculptor Capital LP

    2(b) Address or principal business office or, if none, residence:

    9 West 57th Street, New York, New York 10019

    2(c) Citizenship:

    Delaware

    2(d) Title of class of securities:

    Class A Ordinary Shares, par value $0.0001 per share

    2(e) CUSIP No.:

    G3619H102

     

    Item 3.

    If this statement is filed pursuant to §§240.13d–1(b) or 240.13d–2(b) or (c), check whether the person filing is a:

     

    (a)   ☐    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)   ☐    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)   ☐    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)   ☐    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a–8);
    (e)   ☐    An investment adviser in accordance with §240.13d–1(b)(1)(ii)(E);
    (f)   ☐    An employee benefit plan or endowment fund in accordance with §240.13d–1(b)(1)(ii)(F);
    (g)   ☐    A parent holding company or control person in accordance with §240.13d–1(b)(1)(ii)(G);
    (h)   ☐    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)   ☐    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a–3);
    (j)   ☐    A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J);
    (k)   ☐    Group, in accordance with §240.13d–1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J), please specify the type of institution: ________________________________


    Item 4.

    Ownership

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

    (a) Amount beneficially owned: 1,242,391

    (b) Percent of class: 9.82%


    SCHEDULE 13G

    (c) Number of shares as to which the person has:

    (i) Sole power to vote or to direct the vote 0.

    (ii) Shared power to vote or to direct the vote 1,242,391.

    (iii) Sole power to dispose or to direct the disposition of 0.

    (iv) Shared power to dispose or to direct the disposition of 1,242,391.

    Sculptor and Sculptor-II serve as the principal investment managers to the Accounts and thus may be deemed beneficial owners of the Ordinary Shares in the Accounts managed by Sculptor and Sculptor-II. SCHC-II serves as the sole general partner of Sculptor-II and is wholly owned by Sculptor. SCHC serves as the sole general partner of Sculptor. As such, SCHC and SCHC-II may be deemed to control Sculptor as well as Sculptor-II and, therefore, may be deemed to be the beneficial owners of the Ordinary Shares reported in this Schedule 13G. SCU is the sole shareholder of SCHC, and, for purposes of this Schedule 13G, may be deemed a beneficial owner of the Ordinary Shares reported herein. 

    The percentages reported in this Schedule 13G have been calculated based on 12,650,000 shares of Class A Ordinary Shares outstanding, as reported in the Issuer’s Form 10-Q filed August 14, 2023.

     

    Item 5.

    Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐.

    Dissolution of a group requires a response to this item.

     

    Item 6.

    Ownership of More than 5 Percent on Behalf of Another Person.

    See Item 4.

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

    N/A

     

    Item 8.

    Identification and Classification of Members of the Group.

    See Item 4.

     

    Item 9.

    Notice of Dissolution of Group.

    N/A

     

    Item 10.

    Certifications

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect other than activities solely in connection with a nomination under §240.14a-11.


    Signatures

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Date: October 10, 2023       SCULPTOR CAPITAL LP
          By: Sculptor Capital Holding Corporation, its General Partner
          Signature:/s/ Wayne Cohen
          Name: Wayne Cohen
          Title: President and Chief Operating Officer
          SCULPTOR CAPITAL II LP
          By: Sculptor Capital Holding II LLC, its General Partner
          By: Sculptor Capital LP, its Member
          By: Sculptor Capital Holding Corporation, its General Partner
          Signature:/s/ Wayne Cohen
          Name: Wayne Cohen
            Title: President and Chief Operating Officer
          SCULPTOR CAPITAL HOLDING CORPORATION
          Signature:/s/ Wayne Cohen
          Name: Wayne Cohen
          Title: President and Chief Operating Officer
          SCULPTOR CAPITAL HOLDING II LLC
          Signature:/s/ Wayne Cohen
          Name: Wayne Cohen
          Title: President and Chief Operating Officer
          SCULPTOR CAPITAL MANAGEMENT, INC.
          Signature:/s/ Wayne Cohen
          Name: Wayne Cohen
          Title: President and Chief Operating Officer
          SCULPTOR MASTER FUND, LTD.
          By: Sculptor Capital LP, its investment manager
          By: Sculptor Capital Holding Corporation, its General Partner
          Signature:/s/ Wayne Cohen
          Name: Wayne Cohen
          Title: President and Chief Operating Officer
          SCULPTOR SPECIAL FUNDING, LP
          By: Sculptor Capital LP, its investment manager
          By: Sculptor Capital Holding Corporation, its General Partner
          Signature:/s/ Wayne Cohen
          Name: Wayne Cohen
          Title: President and Chief Operating Officer
          SCULPTOR CREDIT OPPORTUNITIES MASTER FUND, LTD.
          By: Sculptor Capital LP, its Investment Manager
          By: Sculptor Capital Holding Corporation, its General Partner
          Signature:/s/ Wayne Cohen
          Name: Wayne Cohen
          Title: President and Chief Operating Officer
          SCULPTOR SC II LP
          By: Sculptor Capital II LP, its Investment Manager
          By: Sculptor Capital Holding II LLC, its General Partner
          By: Sculptor Capital LP, its Member
          By: Sculptor Capital Holding Corporation, its General Partner
          Signature:/s/ Wayne Cohen
          Name: Wayne Cohen
          Title: President and Chief Operating Officer
    Get the next $FRBN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FRBN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $FRBN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    enGene Appoints Richard Bryce, MBChB, MRCGP, MFPM, as Chief Medical Officer

    BOSTON and MONTREAL, Sept. 7, 2023 /PRNewswire/ - enGene, Inc., a clinical-stage biotechnology company mainstreaming gene therapy through its novel platform for the delivery of therapeutics to mucosal tissues and other organs, today announced the appointment of Richard Bryce, MBChB, MRCGP, MFPM as its Chief Medical Officer, effective September 19, 2023. Dr. Bryce will oversee the clin­i­cal develop­ment of EG-70, enGene's lead product candidate for non-muscle invasive bladder cancer (NMIBC), as well as the devel­op­ment strat­e­gy for enGene's ther­a­peu­tic pipeline of tissue-targeted non-viral gene therapies.

    9/7/23 7:00:00 AM ET
    $FRBN
    Blank Checks
    Finance

    enGene, Inc. and Forbion European Acquisition Corp. ("FEAC", Nasdaq: FRBN) Announce Business Combination Agreement to Create Nasdaq-Listed Biotechnology Company Developing Next-Generation Non-Viral, Locally Administered Gene Therapies

    Leading institutional investors commit $135 million USD in transaction financing, anchored by FEAC's sponsor, Forbion Growth Sponsor FEAC I B.V. (together with its parent entity Forbion Growth Opportunities Fund I Cooperatief U.A., "Forbion Growth").enGene is a clinical-stage biotechnology company developing non-viral gene therapies based on its proprietary dually derivatized chitosan ("DDX") platform that are re-dosable, manufacturable at scale and designed to be seamlessly integrated into community clinical practices across the globe.Net proceeds are expected to be used to finance enGene's operations through multiple potential value inflection milestones towards a potential Biologics Licen

    5/17/23 7:00:28 AM ET
    $FRBN
    Blank Checks
    Finance

    VectivBio Announces Results of Extraordinary General Meeting

    BASEL, Switzerland, Dec. 09, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG ("VectivBio") (NASDAQ:VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, announced today that Wouter Joustra was elected as a new member of the Board of Directors at the Extraordinary General Meeting held on December 9, 2022. Mr. Wouter Joustra brings a breadth of capital markets and investment experience in the life sciences investment industry to VectivBio. He joined Forbion, a leading European life sciences venture capital firm, in October 2019, where he is currently General Partner. At Forbion, Mr. Joustra is responsible for deal originatio

    12/9/22 4:01:00 PM ET
    $FRBN
    $VECT
    Blank Checks
    Finance
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $FRBN
    SEC Filings

    View All

    SEC Form 15-12G filed by Forbion European Acquisition Corp.

    15-12G - Forbion European Acquisition Corp. (0001874495) (Filer)

    11/13/23 6:45:16 AM ET
    $FRBN
    Blank Checks
    Finance

    Forbion European Acquisition Corp. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Control of Registrant, Material Modification to Rights of Security Holders, Regulation FD Disclosure

    8-K - Forbion European Acquisition Corp. (0001874495) (Filer)

    11/1/23 5:53:05 PM ET
    $FRBN
    Blank Checks
    Finance

    SEC Form 25-NSE filed by Forbion European Acquisition Corp.

    25-NSE - Forbion European Acquisition Corp. (0001874495) (Subject)

    10/31/23 5:07:48 PM ET
    $FRBN
    Blank Checks
    Finance

    $FRBN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Forbion Growth Sponsor Feac I B.V. returned 3,373,496 units of Class A Ordinary Shares to the company (SEC Form 4)

    4 - Forbion European Acquisition Corp. (0001874495) (Issuer)

    10/31/23 7:05:31 PM ET
    $FRBN
    Blank Checks
    Finance

    Forbion Growth Sponsor Feac I B.V. converted options into 1,373,496 units of Class A Ordinary Shares (SEC Form 4)

    4 - Forbion European Acquisition Corp. (0001874495) (Issuer)

    10/31/23 6:59:26 PM ET
    $FRBN
    Blank Checks
    Finance

    New insider Forbion Growth Sponsor Feac I B.V. claimed ownership of 2,000,000 units of Class A Ordinary Shares (SEC Form 3) (Amendment)

    3/A - Forbion European Acquisition Corp. (0001874495) (Issuer)

    10/31/23 6:12:51 PM ET
    $FRBN
    Blank Checks
    Finance

    $FRBN
    Leadership Updates

    Live Leadership Updates

    View All

    enGene Appoints Richard Bryce, MBChB, MRCGP, MFPM, as Chief Medical Officer

    BOSTON and MONTREAL, Sept. 7, 2023 /PRNewswire/ - enGene, Inc., a clinical-stage biotechnology company mainstreaming gene therapy through its novel platform for the delivery of therapeutics to mucosal tissues and other organs, today announced the appointment of Richard Bryce, MBChB, MRCGP, MFPM as its Chief Medical Officer, effective September 19, 2023. Dr. Bryce will oversee the clin­i­cal develop­ment of EG-70, enGene's lead product candidate for non-muscle invasive bladder cancer (NMIBC), as well as the devel­op­ment strat­e­gy for enGene's ther­a­peu­tic pipeline of tissue-targeted non-viral gene therapies.

    9/7/23 7:00:00 AM ET
    $FRBN
    Blank Checks
    Finance

    $FRBN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Forbion European Acquisition Corp. (Amendment)

    SC 13G/A - Forbion European Acquisition Corp. (0001874495) (Subject)

    2/14/24 4:55:28 PM ET
    $FRBN
    Blank Checks
    Finance

    SEC Form SC 13G filed by Forbion European Acquisition Corp.

    SC 13G - Forbion European Acquisition Corp. (0001874495) (Subject)

    2/14/24 6:00:38 AM ET
    $FRBN
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Forbion European Acquisition Corp. (Amendment)

    SC 13G/A - Forbion European Acquisition Corp. (0001874495) (Subject)

    2/8/24 12:51:47 PM ET
    $FRBN
    Blank Checks
    Finance